Logotype for Novabay Pharmaceuticals Inc

Novabay Pharmaceuticals (NBY) investor relations material

Novabay Pharmaceuticals Q3 2025 earnings summary

Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.
Logotype for Novabay Pharmaceuticals Inc
Q3 2025 earnings summary7 Nov, 2025

Executive summary

  • Completed divestitures of eyecare (Avenova), wound care (PhaseOne), and skin care (DERMAdoctor) businesses in early 2025, shifting to a single wound care segment and exploring new strategic directions, including blockchain-based assets.

  • Board approved a Plan of Dissolution but ultimately opted for a new capital allocation strategy, entering into significant preferred stock and warrant transactions.

  • Regained compliance with NYSE American equity requirements following capital raises and strategic actions.

Financial highlights

  • Net product revenue from continuing operations was $0.5 million for both the three and nine months ended September 30, 2025, up from zero in the prior year periods due to a large order from a Chinese distributor.

  • Net loss from continuing operations was $1.3 million for the quarter and $6.6 million for the nine months, both improved from prior year losses.

  • Net income for the nine months was $4.5 million, driven by $11.1 million in net income from discontinued operations, primarily from the Avenova divestiture.

  • General and administrative expenses were $1.2 million for the quarter and $5.8 million for the nine months, with a decrease in the quarter and a slight increase year-over-year.

  • Recorded $676,000 in impairment charges for the nine months, mainly related to lease right-of-use assets.

  • Paid a special cash dividend of $4.8 million in September 2025.

Outlook and guidance

  • Management believes existing cash and proceeds from recent financings will fund operations through at least November 2026, but strategic direction may change, impacting spending.

  • Company is evaluating opportunities in emerging financial infrastructure and blockchain-based markets.

Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.

Next Novabay Pharmaceuticals earnings date

Logotype for Novabay Pharmaceuticals Inc
Q4 202531 Mar, 2026
Your earnings 
season toolkit.
Download
Free on both iOS & Android.

Next Novabay Pharmaceuticals earnings date

Logotype for Novabay Pharmaceuticals Inc
Q4 202531 Mar, 2026

The essential earnings season companion

The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.

Live calls and transcripts

Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.

Find what you need faster

Search for any keyword across all transcripts simultaneously.

Easily store key findings

Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Your watchlist. Your dashboard.

Follow the companies that matter to you. Get a personalized feed with real-time updates.

Be the first to know

Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.

Consensus estimates

Access analyst consensus estimates, valuation multiples, and revenue segments splits.

All IR material in one place

The easiest way to stay updated during earnings season.

Global coverage

All events from public companies. Live and recorded.

Just click and listen

No webcast links. No manual registrations.

Research anytime, anywhere

Built for professionals. Loved by everyone. Try our free mobile app.

excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
App-store-avatar.png play-store-avatar.png
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
play-store-avatar
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
App-store-avatar.png play-store-avatar.png
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
x-avatar
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
App-store-avatar.png play-store-avatar.png
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
x-avatar
@theshortbearx.com

Frequently asked questions

NovaBay Pharmaceuticals Inc. is a biopharmaceutical company that focuses on the development and commercialization of innovative products for the eye care market. The company specializes in creating novel, fast-acting, synthetic anti-infectives designed to mimic the body’s natural defense mechanisms against infection. Its product portfolio includes solutions for eye care, such as Avenova, an antimicrobial lid and lash solution, as well as products for wound care and skincare. The company is headquartered in Emeryville, California, and its shares are listed on the NYSE.

Quartr provides global coverage of all investor relation material from public companies.

  • Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.

  • Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.

  • Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.

Yes, the Quartr mobile app is free on both iOS and Android.

Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.

Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.

Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.

Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.

Explore our global coverage